{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:56:49Z","timestamp":1781146609052,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Project of Yancheng Municipal Health Commission","award":["YK2024074"],"award-info":[{"award-number":["YK2024074"]}]},{"name":"Basic Research Program of the Yancheng Municipal Bureau of Science and Technology","award":["YK2024074"],"award-info":[{"award-number":["YK2024074"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02378-7","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:06:53Z","timestamp":1777270013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics single-cell dissection of malignant epithelial heterogeneity identifies GJB2 as an EMT-driving biomarker in triple-negative breast cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Hongjie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"2378_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5306\/wjco.v12.i3.164","volume":"12","author":"D O'Reilly","year":"2021","unstructured":"O\u2019Reilly D, Sendi MA, Kelly CM. Overview of recent advances in metastatic triple negative breast cancer. World J Clin Oncol. 2021;12(3):164\u201382.","journal-title":"World J Clin Oncol"},{"issue":"11","key":"2378_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2378_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mdr2.70040","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Jiang A, Zhang Y, Wang Q, Li Z, et al. Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med Research. 2025;1(3):397\u2013411.","journal-title":"Med Research"},{"issue":"6","key":"2378_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang P, Liang X, Ye B, Wang X, Wang Y, Gong Z, et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: targeting SLC25A1 to overcome immune resistance. Chin J Cancer Res. 2025;37(6):1000\u201319.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"2378_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong Z, Du M, Li Y, Ye B, Huang Y, Gong H, et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit Med. 2025;8(1):796.","journal-title":"NPJ Digit Med"},{"key":"2378_CR6","doi-asserted-by":"publisher","first-page":"1431418","DOI":"10.3389\/fonc.2024.1431418","volume":"14","author":"M Haque","year":"2024","unstructured":"Haque M, Shyanti RK, Mishra MK. Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer. Front Oncol. 2024;14:1431418.","journal-title":"Front Oncol"},{"issue":"1","key":"2378_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z, et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct Target Ther. 2024;9(1):192.","journal-title":"Signal Transduct Target Ther"},{"key":"2378_CR8","doi-asserted-by":"publisher","first-page":"1669741","DOI":"10.3389\/fgene.2025.1669741","volume":"16","author":"X Han","year":"2025","unstructured":"Han X, Li X, Bai L, Zhang G. Single-cell transcriptomics in metastatic breast cancer: mapping tumor evolution and therapeutic resistance. Front Genet. 2025;16:1669741.","journal-title":"Front Genet"},{"key":"2378_CR9","doi-asserted-by":"publisher","first-page":"976388","DOI":"10.3389\/fnmol.2022.976388","volume":"15","author":"P Chen","year":"2022","unstructured":"Chen P, Wu W, Zhang J, Chen J, Li Y, Sun L, et al. Pathological mechanisms of connexin26-related hearing loss: Potassium recycling, ATP-calcium signaling, or energy supply? Front Mol Neurosci. 2022;15:976388.","journal-title":"Front Mol Neurosci"},{"key":"2378_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fnmol.2017.00428","volume":"10","author":"FJ Del Castillo","year":"2017","unstructured":"Del Castillo FJ, Del Castillo I. DFNB1 non-syndromic hearing impairment: diversity of mutations and associated phenotypes. Front Mol Neurosci. 2017;10:428.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2378_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/cancers13010058","volume":"13","author":"CX Chen","year":"2020","unstructured":"Chen CX, Luo KJ, Yang JP, Huang YC, Cardenas ER, Nicholson BJ, et al. Connexins and cAMP cross-talk in cancer progression and metastasis. Cancers (Basel). 2020;13(1):58.","journal-title":"Cancers (Basel)"},{"key":"2378_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fgene.2019.00317","volume":"10","author":"G Chen","year":"2019","unstructured":"Chen G, Ning B, Shi T. Single-cell RNA-Seq technologies and related computational data analysis. Front Genet. 2019;10:317.","journal-title":"Front Genet"},{"key":"2378_CR13","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee HO, Lee KM, Lee HB, Kim KT, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8:15081.","journal-title":"Nat Commun"},{"issue":"3","key":"2378_CR14","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.3390\/ijms24032943","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Sun ST, Zhang XY, Ding HR, Yuan Y, He JJ, et al. The evolution of single-cell RNA sequencing technology and application: progress and perspectives. Int J Mol Sci. 2023;24(3):2943.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2378_CR15","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12(5):R68.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"2378_CR16","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367.","journal-title":"J Clin Invest"},{"issue":"7","key":"2378_CR17","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21(7):1688\u201398.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2378_CR18","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1073\/pnas.1017626108","volume":"109","author":"PJ Keller","year":"2012","unstructured":"Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A. 2012;109(8):2772\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2378_CR19","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1158\/1078-0432.CCR-23-2976","volume":"30","author":"K Luthria","year":"2024","unstructured":"Luthria K, Shah P, Caldwell B, Melms JC, Abuzaid S, Jakubikova V, et al. Single-cell profiling of sarcomas from archival tissue reveals programs associated with resistance to immune checkpoint blockade. Clin Cancer Res. 2024;30(19):4530\u201341.","journal-title":"Clin Cancer Res"},{"key":"2378_CR20","doi-asserted-by":"publisher","first-page":"e43803","DOI":"10.7554\/eLife.43803","volume":"8","author":"D Kotliar","year":"2019","unstructured":"Kotliar D, Veres A, Nagy MA, Tabrizi S, Hodis E, Melton DA, et al. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife. 2019;8:e43803.","journal-title":"Elife"},{"issue":"7","key":"2378_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3727\/096504020X16100888208039","volume":"28","author":"H Wang","year":"2021","unstructured":"Wang H, Hu X, Yang F, Xiao H. miR-325-3p promotes the proliferation, invasion, and EMT of breast cancer cells by directly targeting S100A2. Oncol Res. 2021;28(7):731\u201344.","journal-title":"Oncol Res"},{"key":"2378_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","volume":"92","author":"HY Liao","year":"2021","unstructured":"Liao HY, Da CM, Liao B, Zhang HH. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem. 2021;92:9\u201318.","journal-title":"Clin Biochem"},{"issue":"3","key":"2378_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/onc.2013.553","volume":"34","author":"I Moy","year":"2015","unstructured":"Moy I, Todorovi\u0107 V, Dubash AD, Coon JS, Parker JB, Buranapramest M, et al. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells. Oncogene. 2015;34(3):323\u201333.","journal-title":"Oncogene"},{"issue":"Pt 2","key":"2378_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/bj3500453","volume":"350 Pt 2","author":"DA Jellinek","year":"2000","unstructured":"Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J. 2000;350 Pt 2(Pt 2):453\u201361.","journal-title":"Biochem J"},{"issue":"1","key":"2378_CR25","doi-asserted-by":"publisher","first-page":"8267","DOI":"10.1038\/s41598-018-26636-6","volume":"8","author":"S Tiwary","year":"2018","unstructured":"Tiwary S, Morales JE, Kwiatkowski SC, Lang FF, Rao G, McCarty JH. Metastatic brain tumors disrupt the blood-brain barrier and alter lipid metabolism by inhibiting expression of the endothelial cell fatty acid transporter Mfsd2a. Sci Rep. 2018;8(1):8267.","journal-title":"Sci Rep"},{"issue":"3","key":"2378_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41419-022-04725-9","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen Y, Zhang Z, Tao X, Xu S, Zhang X, et al. Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice. Cell Death Dis. 2022;13(3):279.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2378_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"key":"2378_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"2378_CR29","doi-asserted-by":"publisher","first-page":"10945","DOI":"10.18632\/oncotarget.23760","volume":"9","author":"Z Sun","year":"2018","unstructured":"Sun Z, Wang CY, Lawson DA, Kwek S, Velozo HG, Owyong M, et al. Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells. Oncotarget. 2018;9(13):10945\u201361.","journal-title":"Oncotarget"},{"issue":"1","key":"2378_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"Luo L, Yang P, Mastoraki S, Rao X, Wang Y, Kettner NM, et al. Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer. Mol Cancer. 2025;24(1):48.","journal-title":"Mol Cancer"},{"issue":"1","key":"2378_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbrc.2010.03.098","volume":"395","author":"A Terrinoni","year":"2010","unstructured":"Terrinoni A, Codispoti A, Serra V, Bruno E, Didona B, Paradisi M, et al. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss. Biochem Biophys Res Commun. 2010;395(1):25\u201330.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2378_CR32","first-page":"537","volume":"11","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Grossman HB. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep. 2004;11(2):537\u201341.","journal-title":"Oncol Rep"},{"key":"2378_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.lungcan.2021.06.001","volume":"158","author":"A Lu","year":"2021","unstructured":"Lu A, Shi Y, Liu Y, Lin J, Zhang H, Guo Y, et al. Integrative analyses identified ion channel genes GJB2 and SCNN1B as prognostic biomarkers and therapeutic targets for lung adenocarcinoma. Lung Cancer. 2021;158:29\u201339.","journal-title":"Lung Cancer"},{"issue":"1","key":"2378_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1756-9966-29-79","volume":"29","author":"S Nomura","year":"2010","unstructured":"Nomura S, Maeda K, Noda E, Inoue T, Fukunaga S, Nagahara H, et al. Clinical significance of the expression of connexin26 in colorectal cancer. J Exp Clin Cancer Res. 2010;29(1):79.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2378_CR35","doi-asserted-by":"publisher","first-page":"R279","DOI":"10.1530\/REP-14-0661","volume":"149","author":"MK Stewart","year":"2015","unstructured":"Stewart MK, Simek J, Laird DW. Insights into the role of connexins in mammary gland morphogenesis and function. Reproduction. 2015;149(6):R279-290.","journal-title":"Reproduction"},{"issue":"2","key":"2378_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/carcin\/23.2.231","volume":"23","author":"LW Tan","year":"2002","unstructured":"Tan LW, Bianco T, Dobrovic A. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. Carcinogenesis. 2002;23(2):231\u20136.","journal-title":"Carcinogenesis"},{"issue":"6","key":"2378_CR37","first-page":"3645","volume":"40","author":"A Shettar","year":"2018","unstructured":"Shettar A, Damineni S, Mukherjee G, Kondaiah P. Gap junction \u03b2-2 expression is negatively associated with the estrogen receptor status in breast cancer tissues and is a regulator of breast tumorigenesis. Oncol Rep. 2018;40(6):3645\u201353.","journal-title":"Oncol Rep"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02378-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T02:07:03Z","timestamp":1781143623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2378"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02378-7","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}